Cargando…
HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
BACKGROUND: Human papillomavirus (HPV), p16 expression, and TP53 mutations are known prognostic factors in head and neck squamous cell carcinoma, but their role in squamous cell carcinoma of the anal canal (SCCAC) is less well established. The objective of this study was to determine the prognostic...
Autores principales: | Meulendijks, D, Tomasoa, N B, Dewit, L, Smits, P H M, Bakker, R, van Velthuysen, M-L F, Rosenberg, E H, Beijnen, J H, Schellens, J H M, Cats, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402454/ https://www.ncbi.nlm.nih.gov/pubmed/25871546 http://dx.doi.org/10.1038/bjc.2015.20 |
Ejemplares similares
-
Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
por: Meulendijks, D, et al.
Publicado: (2014) -
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
por: Cacheux, Wulfran, et al.
Publicado: (2016) -
Unique volatolomic signatures of TP53 and KRAS in lung cells
por: Davies, M P A, et al.
Publicado: (2014) -
Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer
por: Siriwardena, B S M S, et al.
Publicado: (2006) -
Gene expression reveals two distinct groups of anal carcinomas with clinical implications
por: Bruland, O, et al.
Publicado: (2008)